199 related articles for article (PubMed ID: 10381062)
21. Arrhythmias in systemic lupus erythematosus.
Teixeira RA; Borba EF; Bonfá E; Martinelli Filho M
Rev Bras Reumatol; 2010; 50(1):81-9. PubMed ID: 21125143
[TBL] [Abstract][Full Text] [Related]
22. Progressive heart block in active rheumatoid arthritis.
Adhiyaman V; Oke A; Aziz K; White AD
Int J Clin Pract; 2000 Oct; 54(8):544-5. PubMed ID: 11198736
[TBL] [Abstract][Full Text] [Related]
23. [Complete atrioventricular block following long term treatment with chloroquine].
Puymirat E; Douard H; Roudaut R
Rev Med Interne; 2008 Sep; 29(9):741-3. PubMed ID: 18692276
[TBL] [Abstract][Full Text] [Related]
24. Predictors of complete heart block after transcoronary ablation of septal hypertrophy: results of a prospective electrophysiological investigation in 172 patients with hypertrophic obstructive cardiomyopathy.
Lawrenz T; Lieder F; Bartelsmeier M; Leuner C; Borchert B; Meyer zu Vilsendorf D; Strunk-Mueller C; Reinhardt J; Feuchtl A; Stellbrink C; Kuhn H
J Am Coll Cardiol; 2007 Jun; 49(24):2356-63. PubMed ID: 17572252
[TBL] [Abstract][Full Text] [Related]
25. [Heart conduction disorders in long-term treatment with chloroquine. Two new cases].
Verny C; de Gennes C; Sébastien P; Lê Thi HD; Chapelon C; Piette JC; Chomette G; Godeau P
Presse Med; 1992 May 2-9; 21(17):800-4. PubMed ID: 1535141
[TBL] [Abstract][Full Text] [Related]
26. [Chloroquine-induced myopathy and neuropathy: progressive tetraparesis with areflexia that simulates a polyradiculoneuropathy. Two case reports].
Becerra-Cuñat JL; Coll-Cantí J; Gelpí-Mantius E; Ferrer-Avellí X; Lozano-Sánchez M; Millán-Torné M; Ojanguren I; Ariza A; Olivé A
Rev Neurol; 2003 Mar 16-31; 36(6):523-6. PubMed ID: 12652413
[TBL] [Abstract][Full Text] [Related]
27. [Ocular and cardiac toxicity by chloroquine].
Gentille Lorente DI
Rev Med Chil; 2011 Oct; 139(10):1384-6. PubMed ID: 22286742
[No Abstract] [Full Text] [Related]
28. Double-blind, randomized, controlled clinical trial of clofazimine compared with chloroquine in patients with systemic lupus erythematosus.
Bezerra EL; Vilar MJ; da Trindade Neto PB; Sato EI
Arthritis Rheum; 2005 Oct; 52(10):3073-8. PubMed ID: 16200586
[TBL] [Abstract][Full Text] [Related]
29. More thoughts about antimalarials: should one prescribe chloroquine?
Esdaile JM
J Rheumatol; 1999 Sep; 26(9):1868. PubMed ID: 10493663
[No Abstract] [Full Text] [Related]
30. [Complete atrioventricular block (with Adams-Stokes syndrome) in systemic connective tissue disease. Electrocardiographic development in three patients].
Vachtenheim J
Vnitr Lek; 2002 Dec; 48 Suppl 1():201-5. PubMed ID: 12744047
[TBL] [Abstract][Full Text] [Related]
31. Ocular changes after treatment of chronic discoid lupus erythematosus with chloroquine.
Handa F; Chopra A; Aggarwal RR; Bansal DC
Indian J Dermatol; 1983 Oct; 28(4):145-8. PubMed ID: 6671702
[No Abstract] [Full Text] [Related]
32. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
[TBL] [Abstract][Full Text] [Related]
33. Chloroquine-induced cardiomyopathy-echocardiographic features.
Naqvi TZ; Luthringer D; Marchevsky A; Saouf R; Gul K; Buchbinder NA
J Am Soc Echocardiogr; 2005 Apr; 18(4):383-7. PubMed ID: 15846170
[TBL] [Abstract][Full Text] [Related]
34. Hydroxychloroquine-induced cardiomyopathy that presented as pulmonary hypertension: a newly noted complication.
Bae SM; Jung HO; Ihm SM; Kim JJ; Chin JY; Kim TS; Park SH; Youn HJ; Lee KY
Cardiology; 2012; 123(3):197-200. PubMed ID: 23154245
[TBL] [Abstract][Full Text] [Related]
35. [Chloroquine retinopathy].
Nguyen AL; Tan AN; Lavrijsen APM
Ned Tijdschr Geneeskd; 2018 Dec; 163():. PubMed ID: 30570930
[TBL] [Abstract][Full Text] [Related]
36. [Complete atrioventricular block secondary to pulmonary embolism].
Martí J; Casanovas N; Recasens L; Comín J; García A; Bruguera J
Rev Esp Cardiol; 2005 Feb; 58(2):230-2. PubMed ID: 15743571
[TBL] [Abstract][Full Text] [Related]
37. Safety of extended treatment with anakinra in patients with rheumatoid arthritis.
Fleischmann RM; Tesser J; Schiff MH; Schechtman J; Burmester GR; Bennett R; Modafferi D; Zhou L; Bell D; Appleton B
Ann Rheum Dis; 2006 Aug; 65(8):1006-12. PubMed ID: 16396977
[TBL] [Abstract][Full Text] [Related]
38. An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
van Roon EN; van den Bemt PM; Jansen TL; Houtman NM; van de Laar MA; Brouwers JR
Clin Ther; 2009 Aug; 31(8):1737-46. PubMed ID: 19808132
[TBL] [Abstract][Full Text] [Related]
39. Chloroquine retinopathy in Nigerian patients with heart block.
Magulike NO; Ihenacho HN; Ike VO
Eye (Lond); 1993; 7 ( Pt 4)():591-3. PubMed ID: 8253245
[TBL] [Abstract][Full Text] [Related]
40. Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritis.
Rau R; Sander O; van Riel P; van de Putte L; Hasler F; Zaug M; Kneer J; van der Auwera P; Stevens RM;
J Rheumatol; 2003 Apr; 30(4):680-90. PubMed ID: 12672184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
